34 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
An unprecedented dual antagonist and agonist of human Transglutaminase 2.
Stanford University
Selective inhibition of extracellular thioredoxin by asymmetric disulfides.
Stanford University
New positron emission tomography (PET) radioligand for imagings-1 receptors in living subjects.
Stanford University
The rapamycin-binding domain of the protein kinase mammalian target of rapamycin is a destabilizing domain.
Stanford University
Acylideneoxoindoles: a new class of reversible inhibitors of human transglutaminase 2.
Stanford University
Structure-based design of alpha-amido aldehyde containing gluten peptide analogues as modulators of HLA-DQ2 and transglutaminase 2.
Stanford University
Discovery of azaspirocyclic 1H-3,4,5-Trisubstitued pyrazoles as novel G2019S-LRRK2 selective kinase inhibitors.
Stanford University
Development of a Covalent Inhibitor of c-Jun N-Terminal Protein Kinase (JNK) 2/3 with Selectivity over JNK1.
Stanford University
Structure-activity relationship analysis of the selective inhibition of transglutaminase 2 by dihydroisoxazoles.
Stanford University
Discovery of G2019S-Selective Leucine Rich Repeat Protein Kinase 2 inhibitors with in vivo efficacy.
Stanford University
Boosting the Discovery of Small Molecule Inhibitors of Glucose-6-Phosphate Dehydrogenase for the Treatment of Cancer, Infectious Diseases, and Inflammation.
Stanford University
Synthesis and Structure-Activity relationships of cyclin-dependent kinase 11 inhibitors based on a diaminothiazole scaffold.
Stanford University
Generation of highly potent DYRK1A-dependent inducers of human β-Cell replication via Multi-Dimensional compound optimization.
Stanford University
Inhibition of Chikungunya Virus-Induced Cell Death by Salicylate-Derived Bryostatin Analogues Provides Additional Evidence for a PKC-Independent Pathway.
Stanford University
Selective binding of bryostatin analogues to the cysteine rich domains of protein kinase C isozymes.
Stanford University
Discovery of small molecule inhibitors of human uridine-cytidine kinase 2 by high-throughput screening.
Stanford University
Design of β-amyloid aggregation inhibitors from a predicted structural motif.
Stanford University
High-content single-cell drug screening with phosphospecific flow cytometry.
Stanford University
Structure-activity relationships of semisynthetic mumbaistatin analogs.
Stanford University
Optimization of Isothiazolo[4,3- b]pyridine-Based Inhibitors of Cyclin G Associated Kinase (GAK) with Broad-Spectrum Antiviral Activity.
Stanford University
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
Samumed
Tetrahydroisoquinolines containing substituted azoles as factor XIa inhibitors
Bristol-Myers Squibb
Selectivity determinants of inhibitor binding to human 20alpha-hydroxysteroid dehydrogenase: crystal structure of the enzyme in ternary complex with coenzyme and the potent inhibitor 3,5-dichlorosalicylic acid.
Monash University
Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
University of Queensland